Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Assembly Biosciences (ASMB) over the last 8 years, with Q4 2024 value amounting to $517237.0.

  • Assembly Biosciences' Non-cash Items rose 5162370.0% to $517237.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $517237.0, marking a year-over-year increase of 5162370.0%. This contributed to the annual value of $517237.0 for FY2024, which is 5162370.0% up from last year.
  • Assembly Biosciences' Non-cash Items amounted to $517237.0 in Q4 2024, which was up 5162370.0% from $1000.0 recorded in Q4 2023.
  • Assembly Biosciences' 5-year Non-cash Items high stood at $63.2 million for Q2 2020, and its period low was $1000.0 during Q3 2022.
  • For the 5-year period, Assembly Biosciences' Non-cash Items averaged around $8.3 million, with its median value being $3.5 million (2020).
  • Its Non-cash Items has fluctuated over the past 5 years, first crashed by 9997.65% in 2023, then surged by 5162370.0% in 2024.
  • Assembly Biosciences' Non-cash Items (Quarter) stood at $1.9 million in 2020, then crashed by 97.14% to $53000.0 in 2021, then surged by 7942.05% to $4.3 million in 2022, then crashed by 99.98% to $1000.0 in 2023, then surged by 51623.7% to $517237.0 in 2024.
  • Its last three reported values are $517237.0 in Q4 2024, $1000.0 for Q4 2023, and $4.3 million during Q4 2022.